WO1992012681A1 - Method and device for passageway recanalization - Google Patents

Method and device for passageway recanalization Download PDF

Info

Publication number
WO1992012681A1
WO1992012681A1 PCT/US1992/000339 US9200339W WO9212681A1 WO 1992012681 A1 WO1992012681 A1 WO 1992012681A1 US 9200339 W US9200339 W US 9200339W WO 9212681 A1 WO9212681 A1 WO 9212681A1
Authority
WO
WIPO (PCT)
Prior art keywords
stent
passageway
catheter
radio frequency
balloon
Prior art date
Application number
PCT/US1992/000339
Other languages
French (fr)
Inventor
Krishna Kandarpa
Original Assignee
Brigham And Women's Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Brigham And Women's Hospital filed Critical Brigham And Women's Hospital
Publication of WO1992012681A1 publication Critical patent/WO1992012681A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/08Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by means of electrically-heated probes
    • A61B18/082Probes or electrodes therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/18Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
    • A61B18/20Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser
    • A61B18/22Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser the beam being directed along or through a flexible conduit, e.g. an optical fibre; Couplings or hand-pieces therefor
    • A61B18/28Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser the beam being directed along or through a flexible conduit, e.g. an optical fibre; Couplings or hand-pieces therefor for heating a thermal probe or absorber
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/95Instruments specially adapted for placement or removal of stents or stent-grafts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/22Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
    • A61B2017/22001Angioplasty, e.g. PCTA
    • A61B2017/22002Angioplasty, e.g. PCTA preventing restenosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/22Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
    • A61B2017/22051Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for with an inflatable part, e.g. balloon, for positioning, blocking, or immobilisation
    • A61B2017/22061Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for with an inflatable part, e.g. balloon, for positioning, blocking, or immobilisation for spreading elements apart
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/10Balloon catheters
    • A61M25/104Balloon catheters used for angioplasty

Definitions

  • the present invention relates to a support or stent for the recanalization of an occluded artery or other body passageway. More particularly the invention utilizes a heatable arterial support or stent to repair and prevent restenosis of an occluded blood vessel.
  • occlusions or blockages are formed on the interior wall of the artery.
  • the organ or extremity to which blood is to be supplied is compromised and the patient may experience a myocardial infarction or stroke.
  • Some forms of occlusions may be treated by drugs while others require surgery.
  • percutaneous translu inal balloon angioplasty PTBA
  • dilation of the arterial wall by an inflatable balloon to restore blood flow was an acceptable means of treatment for this condition and was considered to be a less invasive alternative to surgery.
  • PTBA suffers from the disadvantage of a moderate rate of restenosis (the recurrence of blockage) .
  • Arterial stenting involves the placement of an expandable coil spring or wire-mesh tube within the occluded artery to reopen the lumen of the blood vessel.
  • An arterial stent is disclosed in U.S. Patent No. 4,739,762 to Julio Palmaz.
  • the Palmaz device comprises an expandable wire-mesh graft or prosthesis which is mounted upon an inflatable balloon catheter.
  • the catheter assembly including the graft, is delivered to the occluded area and is then inflated to radially force the graft into contact with the occlusion.
  • the graft expands, the lumen of the blood vessel is opened and blood flow is restored.
  • the balloon catheter is deflated and removed, leaving behind the graft to buttress and prevent elastic recoil of the blood vessel wall.
  • the external surface of the balloon is heated to fuse together disrupted tissue elements and to kill smooth muscle cells which are believed to lead to restenosis.
  • the Spears device does not adequately prevent the spontaneous elastic recoil of the arterial wall.
  • the arterial wall begins to spring back to its original shape.
  • stenting in and of itself is ineffective in preventing restenosis due to the occurrence of cellular proliferation.
  • balloon dilation in combination with localized heating does not adequately prevent restenosis since the vessel wall tends to spontaneously return to its original occluded shape.
  • the present invention is a device for permanent recanalization of an occluded blood vessel (or other body passageway) utilizing a stent in combination with a localized tissue heating means.
  • the device includes a stent which is inserted into an occluded body passageway having sufficient radial resistance to recanalize the passageway and a means for heating'the stent to a temperature between 50°C and 100°C.
  • the stent of the present invention may be constructed of metal and may be balloon expandable. Moreover, the stent may be biased to exert a radial force against the occluded passageway when inserted therein.
  • the stent may be heated by a resistive heater, a laser radiation source, an optica fiber, or microwaves (having a frequency sufficient t couple to the material forming the stent) .
  • the device of the present invention also includes stent which is inserted into an occluded body passagewa having sufficient radial resistance to recanalize th passageway and a means for heating the body passageway to temperature between 50°C and 100°C.
  • the body passageway may be heated by an external radio frequency energy source whic may include paired multiple feeder inductor rings positione between a plurality of capacitor plates for producing tuned radio frequency electromagnetic field.
  • the present invention includes a metho for recanalizing an occluded body passageway comprising th steps of introducing a balloon catheter having a sten disposed about the catheter into a passageway to a locationo proximate an occlusion; expanding the balloon cathete thereby expanding the stent; applying heat to the stent; an removing the balloon catheter from the passageway.
  • Th stent for this method of recanalization may be metallic an may be biased to exert a radial force against th passageway.
  • the stent may be heated to a temperatur between " 50°C and 100°C by a resistive heater, a lase radiation source, an optical fiber, or microwaves (having frequency sufficient to couple to the material forming th stent) .
  • the present invention also includes a method fo recanalizing an occluded body passageway comprising th steps of introducing a balloon catheter having a sten disposed about the catheter into a passageway to a location proximate an occlusion; expanding the balloon catheter thereby expanding the stent; applying heat to the tissue of the passageway; and removing the balloon catheter from the passageway.
  • the stent may be heated to a temperature between 50°C and 100°C by an external radio frequency energy source which may include paired multiple feed inductor rings positioned between a plurality of capacitor plates for producing a tuned radio frequency electromagnetic field.
  • Figure 1 is a longitudinal cross-sectional view of an occluded blood vessel
  • Figure 2 is a schematic view of the catheter assembly of the present invention inserted within the occluded blood vessel shown in Figure 1;
  • Figure 3 is an enlarged view of the catheter assembl shown in Figure 2, illustrating the balloon/stent assembl of the catheter in an expanded state;
  • Figure 4 is another view of the expanded balloon/sten assembly shown in Figure 3, illustrating the expande assembly subjected to an activated external radio frequenc source.
  • FIG. 1 a cross-sectional view of an occluded blood vessel is show generally at 10 in Figure 1.
  • the interior wall 14 of bloo vessel 10 is shown having an occlusion 16 which is deposite thereon. Occlusion 16 blocks the flow of blood whic normally travels freely through the vessel centra passageway or lumen 12.
  • Figure 2 the device of the presen invention for the recanalization of an occluded blood vesse is shown.
  • the device generally includes an expandable tube like support or stent 30 and a means for heating the sten (shown at 43 in Figure 4) , each of which will now b described.
  • Catheter 20 is inserted into blood vessel 1 percutaneously using conventional catheter introductio techniques.
  • Catheter 20 is cylindrical in shape and i constructed of a biologically compatible, flexible materia such as polyethylene or any other suitable material whic exhibits these characteristics.
  • the outer diameter of catheter 20 is unifor throughout and is approximately 2 to 3 mm wide. It should b noted however that the outer diameter of balloon 28 may var depending on the size of the blood vessel into which the catheter is to be inserted.
  • the invention may also be used in anatomical environments other than a blood vessel.
  • the size of the catheter, and other components of the invention can be appropriately sized and shaped to accomplish the desired task.
  • catheter 20 is provided with a central passageway or lumen 22 having a uniform inner diameter of approximately 1 mm.
  • a standard guidewire 34 constructed of approximately 0.038" gauge wire or smaller passes through central lumen 22 to assist in the delivery of catheter 20 into occluded artery 10.
  • the distal end 36 of guide wire 34 is slightly curved or bent to prevent accidental puncture of vessel wall 14 during catheter placement.
  • catheter 20 is provided with an inflatable balloon 28 which surrounds catheter 20 and is constructed of a highly elastic material such as polyethylene or any other suitable material which is capable of expanding and returning to its original shape.
  • balloon 28 In i deflated state, balloon 28 is approximately 10 to 60 mm length and approximately 2.5 to 3.5 mm in diamete However, the balloon dimensions may vary depending upon t size of the occluded blood vessel. Balloon 28 should constructed so as to have a length which is at least equ to the length of the vessel occlusion.
  • the stent 3 is open at both ends and is, at the most, equal to t length of the balloon which the stent surrounds. Howeve as stated above with regard to balloon 28 of catheter 20 the length of stent 30 may vary depending upon the size the arterial occlusion which the balloon/stent assembly i intende'd to bridge. Stent 30 is constructed in such manner so that when a radial force is applied from withi its interior, the stent will expand to a predetermine second diameter which is greater than said first diameter Furthermore, the stent is constructed so that it will remai -lo ⁇
  • the stent or support is fabricated of a metal or other suitable material (such as plastic coated metal) which is biologically compatible, exhibits anti-thrombogenic characteristics and is electromagnetically conductive.
  • an insulated grounding wire 38 constructed of an electrically conductive material, such as steel, is secured to and passes along outer wall 23 of catheter 20 and external surface 39 of balloon 28.
  • the distal end 40 of groundwire 38 is removably coupled with stent 30 at 37, while the proximal end 41 of guidewire 38 is grounded externally of the patient as at 42.
  • groundwire 38 may pass anywhere along the outer wall of the catheter and balloon or within the central lume of the catheter so long as it is removably coupled wit stent 30 at its distal end 40.
  • groundwire 3 may be coupled with stent 30 at any other suitable location which allows easy coupling and creates a good electrica contact.
  • the present invention is the use of a stent (fo example, of the type described above) in combination with heating means to recanalize an occluded blood vessel and t inhibit restenosis.
  • th present invention includes a stent which is biased to exer a radial force against a body passageway and a radi frequency energy source to heat the tissue of an occlude blood vessel.
  • an external radi frequency (rf) source 43 such as the RF Electromagneti Field Generation apparatus disclosed in U.S. Patent No 4,674,481 to Bodie, Jr., et al, the disclosure of which i incorporated herein by reference. (It should be noted tha an internal bipolar rf source may also be utilized.)
  • the external r source is activated for a predetermined period of time t produce a predetermined temperature which will heat th tissues of the vessel wall.
  • the preferred temperature fo the destruction of smooth muscle cells is less than 100°C approximately 50°C.
  • the temperature for this procedure may be adjusted by increasing or decreasing the amplitude or frequency of the rf field.
  • the alteration of the magnetic field of the surrounding blood vessel tissues produces heat generating eddy currents within the tissue.
  • the expanded stent 30 and groundwire 38 (which are electromagnetically conductive) act as an electric sink for the electric current formed within the tissues.
  • the heat generated within the tissues of the vessel wall 14 destroys the smooth muscle cells which are believed to lead to restenosis.
  • the secondarily heated stent 30 also assists in the destruction by heating of smooth muscle cells.
  • groundwire 38 is disengaged from stent 30, balloon 28 of catheter 20 is deflated and the entire catheter assembly is removed from the blood vessel 10.
  • stent 30 Upon removal of the catheter, stent 30 remains in its expanded state and is left behind to support and prevent elastic recoil of the vessel wall 14. If needed, the heating treatment may be easily repeated by reinserting the groundwire into the blood vessel, recoupling it to the stent and activating the rf source for the appropriate time period.
  • the stent prope of the present invention may be heated by other hea generating sources. These sources include: microwave (having a wavelength sufficient to couple to the sten material) , electrical resistive heaters, laser radiatio sources or fiber optics.
  • stent 30 is directly heated by the heat generating sourc while the surrounding tissues of vessel wall 14 are heate by conduction. The result however is identical; the smoot muscle cells believed to cause restenosis are destroyed.
  • the device of the present invention is utilized in th following manner.
  • the balloon catheter having the sten in its unexpanded state disposed thereon, is introduced int the blood vessel or passageway via standard balloon cathete introduction methods.
  • the catheter With the assistance of the guidewire the catheter is located proximate the occlusion so that i is bridged by the balloon/stent assembly.
  • the balloo portion of the catheter is then inflated by forcing contrast medium into the balloon through the balloo inflation channel.
  • the inflated balloon exerts a radia force upon, the interior of the stent to expand it into it radially resistive state.
  • the rf source (or other hea generating source) is then activated to heat the surroundin tissues (or stent) to destroy smooth muscle cells Following the heating procedure, the groundwire i disengaged from the stent and the balloon catheter i deflated and removed, leaving behind the stent t permanently support the vessel wall. (Alternatively, the balloon catheter may be deflated and removed prior to heating of the blood vessel tissue.)
  • the present invention not only recanalizes an occluded blood vessel, but destroys the smooth muscle cells which are believed to cause restenosis and provides a permanent support for the blood vessel wall to prevent elastic recoil thereof.
  • the present invention may be introduced into a common bile duct occluded by a cancerous tumor. It has been shown that localized tissue heating in combination with radiation therapy is effective in destroying cancerous tissue cells.
  • the catheter of the present invention including the balloon/stent assembly, may be directed to the cancerous area of the common bile duct for localized tissue heating and cancer cell destruction purposes.
  • the expanded stent may be permanently positioned within the common bile duct to canalize the cancerous area of the passageway.
  • the stent of t present invention may be provided with a heparin polymer t prevent coagulation.
  • the stent may subjected to the radiofrequency energy source available o magnetic resonance imaging (MRI) machines.
  • MRI magnetic resonance imaging

Abstract

The present invention relates to a method and device for the recanalization of an occluded blood vessel (10) which includes an expandable wire-mesh stent or support (30) and an external radio frequency (rf) energy source (43) or other suitable heat generating device. The device of the present invention may also be used to recanalize other occluded body passageways or conduits.

Description

TITLE OF THE INVENTION
"METHOD AND DEVICE FOR PASSAGEWAY RECANALIZATION"
FIELD OF THE INVENTION
The present invention relates to a support or stent for the recanalization of an occluded artery or other body passageway. More particularly the invention utilizes a heatable arterial support or stent to repair and prevent restenosis of an occluded blood vessel.
BACKGROUND OF THE INVENTION
When a patient is suffering from atherosclerosis, significant occlusions or blockages are formed on the interior wall of the artery. As a result of these occlusions, the organ or extremity to which blood is to be supplied is compromised and the patient may experience a myocardial infarction or stroke. Some forms of occlusions may be treated by drugs while others require surgery. In the past, percutaneous translu inal balloon angioplasty (PTBA) , dilation of the arterial wall by an inflatable balloon to restore blood flow, was an acceptable means of treatment for this condition and was considered to be a less invasive alternative to surgery. However, PTBA suffers from the disadvantage of a moderate rate of restenosis (the recurrence of blockage) . It has been shown that approximately 30% of all patients who undergo balloon angioplasty redevelop the occlusion within three months due to the proliferation of cells lining the vessel wall and other atherogenic processes. Often, the wall of the dilated artery tends to spring back to its original shape following deflation of the dilation balloon. Arterial stenting has been introduced as a solution to this recoil of the vessel wall.
Arterial stenting involves the placement of an expandable coil spring or wire-mesh tube within the occluded artery to reopen the lumen of the blood vessel. One example of an arterial stent is disclosed in U.S. Patent No. 4,739,762 to Julio Palmaz. The Palmaz device comprises an expandable wire-mesh graft or prosthesis which is mounted upon an inflatable balloon catheter. The catheter assembly, including the graft, is delivered to the occluded area and is then inflated to radially force the graft into contact with the occlusion. As the graft expands, the lumen of the blood vessel is opened and blood flow is restored. After complete expansion of the graft, the balloon catheter is deflated and removed, leaving behind the graft to buttress and prevent elastic recoil of the blood vessel wall.
Although this method is successful in preventing recoil of the vessel wall, restenosis does occur. Smooth muscle cells which form the vessel wall tend to proliferate and build-up in the newly stented area of the blood vessel. This cellular buildup eventually becomes great enough to block the lumen of the blood vessel. It has recently been determined that localized heating of the blood vessel wall may prevent the proliferation of smooth muscle cells which are believed to cause restenosis. One example of localized blood vessel heating is disclosed in U.S. Patent No. 4,799,479 to Spears. The Spears patent discloses an apparatus for angioplasty having an inflatable balloon catheter which is provided with a meshwork of electrical wires to supply heat to a vessel wall. Following balloon angioplasty, the external surface of the balloon is heated to fuse together disrupted tissue elements and to kill smooth muscle cells which are believed to lead to restenosis. Unfortunately, the Spears device does not adequately prevent the spontaneous elastic recoil of the arterial wall. Immediately following angioplasty, the arterial wall begins to spring back to its original shape. Thus stenting in and of itself is ineffective in preventing restenosis due to the occurrence of cellular proliferation. Likewise, balloon dilation in combination with localized heating does not adequately prevent restenosis since the vessel wall tends to spontaneously return to its original occluded shape.
Accordingly, prior to the development of the present invention, there has been no effective treatment of atherosclerosis which also prevents restenosis of the once occluded blood vessel.
SUMMARY OF THE INVENTION
It is with this problem in mind that the present invention was developed. Unlike the prior art, the present invention is a device for permanent recanalization of an occluded blood vessel (or other body passageway) utilizing a stent in combination with a localized tissue heating means. The device includes a stent which is inserted into an occluded body passageway having sufficient radial resistance to recanalize the passageway and a means for heating'the stent to a temperature between 50°C and 100°C. The stent of the present invention may be constructed of metal and may be balloon expandable. Moreover, the stent may be biased to exert a radial force against the occluded passageway when inserted therein. The stent may be heated by a resistive heater, a laser radiation source, an optica fiber, or microwaves (having a frequency sufficient t couple to the material forming the stent) .
The device of the present invention also includes stent which is inserted into an occluded body passagewa having sufficient radial resistance to recanalize th passageway and a means for heating the body passageway to temperature between 50°C and 100°C. The body passageway ma be heated by an external radio frequency energy source whic may include paired multiple feeder inductor rings positione between a plurality of capacitor plates for producing tuned radio frequency electromagnetic field.
Furthermore, the present invention includes a metho for recanalizing an occluded body passageway comprising th steps of introducing a balloon catheter having a sten disposed about the catheter into a passageway to a locatio proximate an occlusion; expanding the balloon cathete thereby expanding the stent; applying heat to the stent; an removing the balloon catheter from the passageway. Th stent for this method of recanalization may be metallic an may be biased to exert a radial force against th passageway. The stent may be heated to a temperatur between" 50°C and 100°C by a resistive heater, a lase radiation source, an optical fiber, or microwaves (having frequency sufficient to couple to the material forming th stent) . The present invention also includes a method fo recanalizing an occluded body passageway comprising th steps of introducing a balloon catheter having a sten disposed about the catheter into a passageway to a location proximate an occlusion; expanding the balloon catheter thereby expanding the stent; applying heat to the tissue of the passageway; and removing the balloon catheter from the passageway. The stent may be heated to a temperature between 50°C and 100°C by an external radio frequency energy source which may include paired multiple feed inductor rings positioned between a plurality of capacitor plates for producing a tuned radio frequency electromagnetic field.
BRIEF DESCRIPTION OF THE DRAWINGS
Various objects, features, and attendant advantages of the present invention will be more fully appreciated as the same becomes better understood from the following detailed description of the present invention when considered in connection with the accompanying drawings, in which:
Figure 1 is a longitudinal cross-sectional view of an occluded blood vessel;
Figure 2 is a schematic view of the catheter assembly of the present invention inserted within the occluded blood vessel shown in Figure 1; Figure 3 is an enlarged view of the catheter assembl shown in Figure 2, illustrating the balloon/stent assembl of the catheter in an expanded state; and
Figure 4 is another view of the expanded balloon/sten assembly shown in Figure 3, illustrating the expande assembly subjected to an activated external radio frequenc source.
DETAILED DESCRIPTION OF THE DRAWINGS
With continuing reference to the drawing figures i which similar reference numerals are used throughout th description to describe similar features of the invention a cross-sectional view of an occluded blood vessel is show generally at 10 in Figure 1. The interior wall 14 of bloo vessel 10 is shown having an occlusion 16 which is deposite thereon. Occlusion 16 blocks the flow of blood whic normally travels freely through the vessel centra passageway or lumen 12. Turning now to Figure 2, the device of the presen invention for the recanalization of an occluded blood vesse is shown. The device generally includes an expandable tube like support or stent 30 and a means for heating the sten (shown at 43 in Figure 4) , each of which will now b described.
Catheter 20 is inserted into blood vessel 1 percutaneously using conventional catheter introductio techniques. Catheter 20 is cylindrical in shape and i constructed of a biologically compatible, flexible materia such as polyethylene or any other suitable material whic exhibits these characteristics. In its preferre embodiment, the outer diameter of catheter 20 is unifor throughout and is approximately 2 to 3 mm wide. It should b noted however that the outer diameter of balloon 28 may var depending on the size of the blood vessel into which the catheter is to be inserted. In addition, the invention may also be used in anatomical environments other than a blood vessel. One of ordinary skill will recognize that the size of the catheter, and other components of the invention can be appropriately sized and shaped to accomplish the desired task. Throughout its entire length, catheter 20 is provided with a central passageway or lumen 22 having a uniform inner diameter of approximately 1 mm. A standard guidewire 34 constructed of approximately 0.038" gauge wire or smaller passes through central lumen 22 to assist in the delivery of catheter 20 into occluded artery 10. The distal end 36 of guide wire 34 is slightly curved or bent to prevent accidental puncture of vessel wall 14 during catheter placement.
At its distal end 26, catheter 20 is provided with an inflatable balloon 28 which surrounds catheter 20 and is constructed of a highly elastic material such as polyethylene or any other suitable material which is capable of expanding and returning to its original shape. In i deflated state, balloon 28 is approximately 10 to 60 mm length and approximately 2.5 to 3.5 mm in diamete However, the balloon dimensions may vary depending upon t size of the occluded blood vessel. Balloon 28 should constructed so as to have a length which is at least equ to the length of the vessel occlusion. A separate port channel 29, which may pass along outer wall 23 of cathet 20, sealably engages with and opens into balloon 28 at 2 At the appropriate time, a radiographic liquid medium, su as diluted iodinated contrast medium or any other suitab radiographic medium is injected through port 29 to infla balloon 28.
A tube-like support or stent 30, which may take t form of a biased, cylindrical, metallic cage or wire-me
(linked) tube, completely surrounds inflatable balloon 2 and has a first diameter of 2.75 to 3.75 mm. The stent 3 is open at both ends and is, at the most, equal to t length of the balloon which the stent surrounds. Howeve as stated above with regard to balloon 28 of catheter 20 the length of stent 30 may vary depending upon the size the arterial occlusion which the balloon/stent assembly i intende'd to bridge. Stent 30 is constructed in such manner so that when a radial force is applied from withi its interior, the stent will expand to a predetermine second diameter which is greater than said first diameter Furthermore, the stent is constructed so that it will remai -lo¬
in its expanded state upon removal of the radial force. The stent or support is fabricated of a metal or other suitable material (such as plastic coated metal) which is biologically compatible, exhibits anti-thrombogenic characteristics and is electromagnetically conductive.
The apparatus disclosed in U.S. Patent No. 4,739,762 to Julio Palmaz, the disclosure of which is incorporated herein by reference, exhibits the above-described characteristics and would thus be a suitable device for achieving the objectives of the present invention. Other suitable devices include the endoprosthesis disclosed in U.S. Patent 4,877,030 to Beck, et al. and the Schneider "rolling membrane" stent manufactured by Schneider, USA (Minneapolis, MN 55441) . With reference to Figure 3, balloon 28 and stent 30 are shown in their respective expanded states within the occluded blood vessel. Notice that the force of the expanded balloon/stent assembly against occlusion 16 stretches the vessel wall 14 out of its normal shape. As shown in Figure 3, an insulated grounding wire 38, constructed of an electrically conductive material, such as steel, is secured to and passes along outer wall 23 of catheter 20 and external surface 39 of balloon 28. The distal end 40 of groundwire 38 is removably coupled with stent 30 at 37, while the proximal end 41 of guidewire 38 is grounded externally of the patient as at 42. It should be noted that groundwire 38 may pass anywhere along the outer wall of the catheter and balloon or within the central lume of the catheter so long as it is removably coupled wit stent 30 at its distal end 40. Furthermore, groundwire 3 may be coupled with stent 30 at any other suitable locatio which allows easy coupling and creates a good electrica contact.
The present invention is the use of a stent (fo example, of the type described above) in combination with heating means to recanalize an occluded blood vessel and t inhibit restenosis. In its preferred embodiment, th present invention includes a stent which is biased to exer a radial force against a body passageway and a radi frequency energy source to heat the tissue of an occlude blood vessel. Turning now to Figure 4, the expanded balloon/sten assembly of Figure 3 is shown subjected to an external radi frequency (rf) source 43, such as the RF Electromagneti Field Generation apparatus disclosed in U.S. Patent No 4,674,481 to Bodie, Jr., et al, the disclosure of which i incorporated herein by reference. (It should be noted tha an internal bipolar rf source may also be utilized.)
At the appropriate time, that is, when the stent ha been fully expanded within the blood vessel, the external r source is activated for a predetermined period of time t produce a predetermined temperature which will heat th tissues of the vessel wall. The preferred temperature fo the destruction of smooth muscle cells is less than 100°C approximately 50°C. The temperature for this procedure may be adjusted by increasing or decreasing the amplitude or frequency of the rf field. Although not shown, it is possible to place a temperature sensing device within the catheter to monitor heat generation.
When the rf source is activated for the proper time period, the alteration of the magnetic field of the surrounding blood vessel tissues produces heat generating eddy currents within the tissue. The expanded stent 30 and groundwire 38 (which are electromagnetically conductive) act as an electric sink for the electric current formed within the tissues. The heat generated within the tissues of the vessel wall 14 destroys the smooth muscle cells which are believed to lead to restenosis. The secondarily heated stent 30 also assists in the destruction by heating of smooth muscle cells. Upon completion of the heating procedure, groundwire 38 is disengaged from stent 30, balloon 28 of catheter 20 is deflated and the entire catheter assembly is removed from the blood vessel 10. Upon removal of the catheter, stent 30 remains in its expanded state and is left behind to support and prevent elastic recoil of the vessel wall 14. If needed, the heating treatment may be easily repeated by reinserting the groundwire into the blood vessel, recoupling it to the stent and activating the rf source for the appropriate time period. It should be realized, however, that the stent prope of the present invention may be heated by other hea generating sources. These sources include: microwave (having a wavelength sufficient to couple to the sten material) , electrical resistive heaters, laser radiatio sources or fiber optics. In those particular embodiments stent 30 is directly heated by the heat generating sourc while the surrounding tissues of vessel wall 14 are heate by conduction. The result however is identical; the smoot muscle cells believed to cause restenosis are destroyed.
The device of the present invention is utilized in th following manner. The balloon catheter, having the sten in its unexpanded state disposed thereon, is introduced int the blood vessel or passageway via standard balloon cathete introduction methods. With the assistance of the guidewire the catheter is located proximate the occlusion so that i is bridged by the balloon/stent assembly. The balloo portion of the catheter is then inflated by forcing contrast medium into the balloon through the balloo inflation channel. The inflated balloon exerts a radia force upon, the interior of the stent to expand it into it radially resistive state. The rf source (or other hea generating source) is then activated to heat the surroundin tissues (or stent) to destroy smooth muscle cells Following the heating procedure, the groundwire i disengaged from the stent and the balloon catheter i deflated and removed, leaving behind the stent t permanently support the vessel wall. (Alternatively, the balloon catheter may be deflated and removed prior to heating of the blood vessel tissue.)
Thus the present invention not only recanalizes an occluded blood vessel, but destroys the smooth muscle cells which are believed to cause restenosis and provides a permanent support for the blood vessel wall to prevent elastic recoil thereof.
It should be realized that although the use of an external rf source was described, the heat generating sources listed above may be easily substituted and utilized to heat the stent of the present invention.
Furthermore, it should also be realized that the features and attendant advantages of the present invention are also applicable for use within other occluded body passageways or conduits. For example, the present invention may be introduced into a common bile duct occluded by a cancerous tumor. It has been shown that localized tissue heating in combination with radiation therapy is effective in destroying cancerous tissue cells. Thus, the catheter of the present invention, including the balloon/stent assembly, may be directed to the cancerous area of the common bile duct for localized tissue heating and cancer cell destruction purposes. The expanded stent may be permanently positioned within the common bile duct to canalize the cancerous area of the passageway. The invention which is intended to be protected herei should not be construed as limited to the particular for disclosed, as these are to be regarded as illustrati rather than restrictive. For example, the stent of t present invention may be provided with a heparin polymer t prevent coagulation. Additionally, the stent may subjected to the radiofrequency energy source available o magnetic resonance imaging (MRI) machines.
Variations and changes may be made by those skilled i the art without departing from the spirit of the invention
Accordingly, the foregoing detailed description should b considered exemplary in nature and not limited to the scop and spirit of the invention as set forth in the followin claims.

Claims

WHAT IS CLAIMED IS:
1. A device for recanalization of an occluded body passageway, comprising: a stent, wherein said stent may be inserted into said occluded body passageway and has sufficient radial resistance to recanalize said passageway; and means for heating said stent to a temperature between 50°C and 100°C.
1. The device of claim 1, wherein said stent is a balloon expandable stent.
2. The device of claim 1, wherein said stent is biased to exert a radial force against the passageway.
3. The device of claim 1, wherein said means for heating said stent is a resistive heater.
4. The device of claim 1, wherein said means for heating said stent generates microwaves at a frequency sufficient to couple to the material forming the stent.
5. The device of claim 1, wherein said means for heating said stent is a laser radiation source. 6. The device of claim 1, wherein said means for heatin said stent is an optical fiber.
7. The device of claim 1, wherein said stent is metallic.
8. A device for recanalization of an occluded bod passageway, comprising: a stent, wherein said stent may be inserted into said occluded body passageway and has sufficient radial resistance to recanalize said passageway; and a means for heating said body passageway to a temperature between 50°C and 100°C.
9. The device of claim 9, wherein said stent is a balloon expandable stent.
10. The device of claim 9, wherein said stent is biased to exert a radial force against said body passageway.
11. The device of claim 9, wherein said means for heating said body passageway is a radio frequency source.
12. The device of claim 12, wherein said radio frequency source is external to said body passageway.
13. The device of claim 13, wherein said radio frequency source includes paired multiple feed inductor rings positioned between a plurality of capacitor plates for producing a tuned radio frequency electromagnetic field.
14. The device of claim 9, wherein said stent is metallic.
15. A method for recanalizing an occluded body passageway comprising the steps of: a) introducing a balloon catheter having a stent disposed about said catheter into a passageway to a location proximate an occlusion; b) expanding said balloon catheter thereby expanding said stent; c) applying heat to said stent; and d) removing said balloon catheter from said passageway.
17. The method of claim 16, wherein said stent is metallic.
18. The method of claim 16, wherein said stent is heated to a temperature between 50CC and 100°C.
19. The method of claim 16, wherein said stent is biased to exert a radial force against the passageway.
20. The method of claim 16, wherein said heat is generated by a resistive heater. 21. The method of claim 16, wherein said heat is generate by microwaves at a frequency sufficient to couple to th material forming the stent.
22. The method of claim 16, wherein said heat is generate by a laser radiation source.
23. The method of claim 16, wherein said heat is generated by an optical fiber.
10
24. A method for recanalizing an occluded body passageway comprising the steps of: a) introducing a balloon catheter having a stent disposed about said catheter into a passageway to a location
15 proximate an occlusion; b) expanding said balloon catheter thereby expanding said stent; c) applying heat to the tissue of said passageway; and
20 d) removing said balloon catheter from said passageway.
25. The* ethod of claim 24, wherein said stent is metallic.
" 25 26. The method of claim 24, wherein said stent is biased to exert a radial force against the passageway. 27. The method of claim 24, wherein said passageway is heated to a temperature between 50°C and 100°C.
28. The method of claim 24, wherein said heat is generated by a radio frequency source.
29. The method of claim 28, wherein said radio frequency source is external to said passageway.
30. The method of claim 29, wherein said radio frequency energy source includes paired multiple feed inductor rings positioned between a plurality of capacitor plates for producing a tuned radio frequency electromagnetic field.
PCT/US1992/000339 1991-01-16 1992-01-15 Method and device for passageway recanalization WO1992012681A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US641,890 1991-01-16
US07/641,890 US5178618A (en) 1991-01-16 1991-01-16 Method and device for recanalization of a body passageway

Publications (1)

Publication Number Publication Date
WO1992012681A1 true WO1992012681A1 (en) 1992-08-06

Family

ID=24574282

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1992/000339 WO1992012681A1 (en) 1991-01-16 1992-01-15 Method and device for passageway recanalization

Country Status (3)

Country Link
US (1) US5178618A (en)
AU (1) AU1194392A (en)
WO (1) WO1992012681A1 (en)

Cited By (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997032532A1 (en) * 1996-03-05 1997-09-12 Vnus Medical Technologies, Inc. Vascular catheter-based system for heating tissue
US5891134A (en) * 1996-09-24 1999-04-06 Goble; Colin System and method for applying thermal energy to tissue
US6014589A (en) * 1997-11-12 2000-01-11 Vnus Medical Technologies, Inc. Catheter having expandable electrodes and adjustable stent
US6033397A (en) * 1996-03-05 2000-03-07 Vnus Medical Technologies, Inc. Method and apparatus for treating esophageal varices
US6036687A (en) * 1996-03-05 2000-03-14 Vnus Medical Technologies, Inc. Method and apparatus for treating venous insufficiency
US6135997A (en) * 1996-03-05 2000-10-24 Vnus Medical Technologies, Inc. Method for treating hemorrhoids
US6152899A (en) * 1996-03-05 2000-11-28 Vnus Medical Technologies, Inc. Expandable catheter having improved electrode design, and method for applying energy
US6165172A (en) * 1997-09-11 2000-12-26 Vnus Medical Technologies, Inc. Expandable vein ligator catheter and method of use
US6179832B1 (en) 1997-09-11 2001-01-30 Vnus Medical Technologies, Inc. Expandable catheter having two sets of electrodes
US6231507B1 (en) 1997-06-02 2001-05-15 Vnus Medical Technologies, Inc. Pressure tourniquet with ultrasound window and method of use
US6398780B1 (en) 1997-09-11 2002-06-04 Vnus Medical Technologies, Inc. Expandable vein ligator catheter and method of use
US6544278B1 (en) 1998-11-06 2003-04-08 Scimed Life Systems, Inc. Rolling membrane stent delivery system
US6752803B2 (en) 1997-09-11 2004-06-22 Vnus Medical Technologies, Inc. Method and apparatus for applying energy to biological tissue including the use of tumescent tissue compression
US6767360B1 (en) 2001-02-08 2004-07-27 Inflow Dynamics Inc. Vascular stent with composite structure for magnetic reasonance imaging capabilities
EP1549247A1 (en) * 2002-09-30 2005-07-06 Mediplex Corporation Drug release from antithrombogenic multi-layer coated stent
US9547123B2 (en) 2007-04-27 2017-01-17 Covidien Lp Systems and methods for treating hollow anatomical structures
US9770297B2 (en) 2008-06-04 2017-09-26 Covidien Lp Energy devices and methods for treating hollow anatomical structures
US9931232B2 (en) 2010-10-21 2018-04-03 Boston Scientific Scimed, Inc. Stent delivery system

Families Citing this family (194)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5662701A (en) * 1989-08-18 1997-09-02 Endovascular Instruments, Inc. Anti-stenotic method and product for occluded and partially occluded arteries
US5571169A (en) * 1993-06-07 1996-11-05 Endovascular Instruments, Inc. Anti-stenotic method and product for occluded and partially occluded arteries
USRE41029E1 (en) 1990-03-13 2009-12-01 The Regents Of The University Of California Endovascular electrolytically detachable wire and tip for the formation of thrombus in arteries, veins, aneurysms, vascular malformations and arteriovenous fistulas
US6083220A (en) 1990-03-13 2000-07-04 The Regents Of The University Of California Endovascular electrolytically detachable wire and tip for the formation of thrombus in arteries, veins, aneurysms, vascular malformations and arteriovenous fistulas
US5851206A (en) * 1990-03-13 1998-12-22 The Regents Of The University Of California Method and apparatus for endovascular thermal thrombosis and thermal cancer treatment
USRE42625E1 (en) 1990-03-13 2011-08-16 The Regents Of The University Of California Endovascular electrolytically detachable wire and tip for the formation of thrombus in arteries, veins, aneurysms, vascular malformations and arteriovenous fistulas
US5190540A (en) * 1990-06-08 1993-03-02 Cardiovascular & Interventional Research Consultants, Inc. Thermal balloon angioplasty
US5348553A (en) * 1991-12-18 1994-09-20 Whitney Douglass G Method for promoting blood vessel healing
US6179824B1 (en) * 1993-05-10 2001-01-30 Arthrocare Corporation System and methods for electrosurgical restenosis of body lumens
US5224953A (en) * 1992-05-01 1993-07-06 The Beth Israel Hospital Association Method for treatment of obstructive portions of urinary passageways
US5540712A (en) * 1992-05-01 1996-07-30 Nitinol Medical Technologies, Inc. Stent and method and apparatus for forming and delivering the same
WO1994000178A1 (en) * 1992-06-26 1994-01-06 Schneider (Usa) Inc. Catheter with expandable wire mesh tip
EP0696185B1 (en) * 1993-04-28 1998-08-12 Focal, Inc. Apparatus, product and use related to intraluminal photothermoforming
US5716410A (en) * 1993-04-30 1998-02-10 Scimed Life Systems, Inc. Temporary stent and method of use
US6915806B2 (en) * 1993-05-10 2005-07-12 Arthrocare Corporation Method for harvesting graft vessel
US5807395A (en) * 1993-08-27 1998-09-15 Medtronic, Inc. Method and apparatus for RF ablation and hyperthermia
US6039749A (en) 1994-02-10 2000-03-21 Endovascular Systems, Inc. Method and apparatus for deploying non-circular stents and graftstent complexes
AU3783195A (en) * 1994-11-15 1996-05-23 Advanced Cardiovascular Systems Inc. Intraluminal stent for attaching a graft
US5603731A (en) * 1994-11-21 1997-02-18 Whitney; Douglass G. Method and apparatus for thwarting thrombosis
US6063081A (en) * 1995-02-22 2000-05-16 Medtronic, Inc. Fluid-assisted electrocautery device
US5897553A (en) 1995-11-02 1999-04-27 Medtronic, Inc. Ball point fluid-assisted electrocautery device
CA2171896C (en) * 1995-03-17 2007-05-15 Scott C. Anderson Multi-anchor stent
US6994689B1 (en) 1995-06-05 2006-02-07 Medtronic Vascular, Inc. Occlusion of a vessel
US6312407B1 (en) 1995-06-05 2001-11-06 Medtronic Percusurge, Inc. Occlusion of a vessel
US5743905A (en) * 1995-07-07 1998-04-28 Target Therapeutics, Inc. Partially insulated occlusion device
US6019757A (en) * 1995-07-07 2000-02-01 Target Therapeutics, Inc. Endoluminal electro-occlusion detection apparatus and method
US5776161A (en) 1995-10-16 1998-07-07 Instent, Inc. Medical stents, apparatus and method for making same
US6287336B1 (en) 1995-10-16 2001-09-11 Medtronic, Inc. Variable flexibility stent
US5895406A (en) * 1996-01-26 1999-04-20 Cordis Corporation Axially flexible stent
US6258116B1 (en) 1996-01-26 2001-07-10 Cordis Corporation Bifurcated axially flexible stent
US5980553A (en) * 1996-12-20 1999-11-09 Cordis Corporation Axially flexible stent
US5938682A (en) * 1996-01-26 1999-08-17 Cordis Corporation Axially flexible stent
US6702846B2 (en) 1996-04-09 2004-03-09 Endocare, Inc. Urological stent therapy system and method
US5830179A (en) * 1996-04-09 1998-11-03 Endocare, Inc. Urological stent therapy system and method
US6629981B2 (en) 2000-07-06 2003-10-07 Endocare, Inc. Stent delivery system
US6413269B1 (en) 2000-07-06 2002-07-02 Endocare, Inc. Stent delivery system
US6012457A (en) * 1997-07-08 2000-01-11 The Regents Of The University Of California Device and method for forming a circumferential conduction block in a pulmonary vein
US6024740A (en) * 1997-07-08 2000-02-15 The Regents Of The University Of California Circumferential ablation device assembly
US5971983A (en) 1997-05-09 1999-10-26 The Regents Of The University Of California Tissue ablation device and method of use
WO1998056324A1 (en) 1997-06-13 1998-12-17 Arthrocare Corporation Electrosurgical systems and methods for recanalization of occluded body lumens
US6855143B2 (en) * 1997-06-13 2005-02-15 Arthrocare Corporation Electrosurgical systems and methods for recanalization of occluded body lumens
US6652515B1 (en) * 1997-07-08 2003-11-25 Atrionix, Inc. Tissue ablation device assembly and method for electrically isolating a pulmonary vein ostium from an atrial wall
US6997925B2 (en) * 1997-07-08 2006-02-14 Atrionx, Inc. Tissue ablation device assembly and method for electrically isolating a pulmonary vein ostium from an atrial wall
US6500174B1 (en) * 1997-07-08 2002-12-31 Atrionix, Inc. Circumferential ablation device assembly and methods of use and manufacture providing an ablative circumferential band along an expandable member
US6966908B2 (en) 1997-07-08 2005-11-22 Atrionix, Inc. Tissue ablation device assembly and method for electrically isolating a pulmonary vein ostium from an atrial wall
US6514249B1 (en) 1997-07-08 2003-02-04 Atrionix, Inc. Positioning system and method for orienting an ablation element within a pulmonary vein ostium
US6869431B2 (en) 1997-07-08 2005-03-22 Atrionix, Inc. Medical device with sensor cooperating with expandable member
US6164283A (en) * 1997-07-08 2000-12-26 The Regents Of The University Of California Device and method for forming a circumferential conduction block in a pulmonary vein
US6070589A (en) 1997-08-01 2000-06-06 Teramed, Inc. Methods for deploying bypass graft stents
US6746476B1 (en) * 1997-09-22 2004-06-08 Cordis Corporation Bifurcated axially flexible stent
EP1027000A4 (en) 1997-10-09 2001-09-12 Camran Nezhat Methods and systems for organ resection
US6231516B1 (en) * 1997-10-14 2001-05-15 Vacusense, Inc. Endoluminal implant with therapeutic and diagnostic capability
US5957975A (en) * 1997-12-15 1999-09-28 The Cleveland Clinic Foundation Stent having a programmed pattern of in vivo degradation
AU1724099A (en) * 1997-12-15 1999-07-05 Prolifix Medical, Inc. Vascular stent for reduction of restenosis
US6656215B1 (en) 2000-11-16 2003-12-02 Cordis Corporation Stent graft having an improved means for attaching a stent to a graft
US6290731B1 (en) 1998-03-30 2001-09-18 Cordis Corporation Aortic graft having a precursor gasket for repairing an abdominal aortic aneurysm
US6887268B2 (en) 1998-03-30 2005-05-03 Cordis Corporation Extension prosthesis for an arterial repair
US8029561B1 (en) 2000-05-12 2011-10-04 Cordis Corporation Drug combination useful for prevention of restenosis
US6228109B1 (en) * 1998-08-31 2001-05-08 Lily Chen Tu Methods for treating atherosclerosis and vulnerable plaques
US7844319B2 (en) * 1998-11-04 2010-11-30 Susil Robert C Systems and methods for magnetic-resonance-guided interventional procedures
US6701176B1 (en) * 1998-11-04 2004-03-02 Johns Hopkins University School Of Medicine Magnetic-resonance-guided imaging, electrophysiology, and ablation
US8244370B2 (en) 2001-04-13 2012-08-14 Greatbatch Ltd. Band stop filter employing a capacitor and an inductor tank circuit to enhance MRI compatibility of active medical devices
US6190403B1 (en) 1998-11-13 2001-02-20 Cordis Corporation Low profile radiopaque stent with increased longitudinal flexibility and radial rigidity
US6607502B1 (en) 1998-11-25 2003-08-19 Atrionix, Inc. Apparatus and method incorporating an ultrasound transducer onto a delivery member
US6129725A (en) * 1998-12-04 2000-10-10 Tu; Lily Chen Methods for reduction of restenosis
US6102908A (en) * 1999-01-04 2000-08-15 Tu; Lily Chen Rotatable apparatus having ablation capabilities
US6210408B1 (en) 1999-02-24 2001-04-03 Scimed Life Systems, Inc. Guide wire system for RF recanalization of vascular blockages
US6730116B1 (en) * 1999-04-16 2004-05-04 Medtronic, Inc. Medical device for intraluminal endovascular stenting
US6317615B1 (en) 1999-04-19 2001-11-13 Cardiac Pacemakers, Inc. Method and system for reducing arterial restenosis in the presence of an intravascular stent
DE19921088C2 (en) * 1999-04-30 2003-08-07 Magforce Applic Gmbh Stent to keep aisle-like structures open
US6758830B1 (en) * 1999-05-11 2004-07-06 Atrionix, Inc. Catheter positioning system
ES2279757T3 (en) 1999-05-11 2007-09-01 Atrionix, Inc. BALL ANCHORING THREAD.
US6331189B1 (en) 1999-10-18 2001-12-18 Medtronic, Inc. Flexible medical stent
US20040243097A1 (en) * 2000-05-12 2004-12-02 Robert Falotico Antiproliferative drug and delivery device
US20050002986A1 (en) * 2000-05-12 2005-01-06 Robert Falotico Drug/drug delivery systems for the prevention and treatment of vascular disease
US8236048B2 (en) * 2000-05-12 2012-08-07 Cordis Corporation Drug/drug delivery systems for the prevention and treatment of vascular disease
US6776796B2 (en) 2000-05-12 2004-08-17 Cordis Corportation Antiinflammatory drug and delivery device
EP1296598B1 (en) * 2000-05-16 2007-11-14 Atrionix, Inc. Apparatus incorporating an ultrasound transducer on a delivery member
AU6682401A (en) 2000-06-13 2001-12-24 Atrionix Inc Surgical ablation probe for forming a circumferential lesion
US6540775B1 (en) * 2000-06-30 2003-04-01 Cordis Corporation Ultraflexible open cell stent
US6532380B1 (en) * 2000-06-30 2003-03-11 Cedars Sinai Medical Center Image guidance for coronary stent deployment
AU777681B2 (en) 2000-09-08 2004-10-28 Atrionix, Inc. Medical device with sensor cooperating with expandable member
US6699278B2 (en) 2000-09-22 2004-03-02 Cordis Corporation Stent with optimal strength and radiopacity characteristics
US20020051730A1 (en) * 2000-09-29 2002-05-02 Stanko Bodnar Coated medical devices and sterilization thereof
US7261735B2 (en) * 2001-05-07 2007-08-28 Cordis Corporation Local drug delivery devices and methods for maintaining the drug coatings thereon
US20020111590A1 (en) * 2000-09-29 2002-08-15 Davila Luis A. Medical devices, drug coatings and methods for maintaining the drug coatings thereon
ATE343969T1 (en) * 2000-09-29 2006-11-15 Cordis Corp COATED MEDICAL DEVICES
US6942692B2 (en) 2000-11-16 2005-09-13 Cordis Corporation Supra-renal prosthesis and renal artery bypass
US7314483B2 (en) * 2000-11-16 2008-01-01 Cordis Corp. Stent graft with branch leg
US7229472B2 (en) 2000-11-16 2007-06-12 Cordis Corporation Thoracic aneurysm repair prosthesis and system
US7267685B2 (en) 2000-11-16 2007-09-11 Cordis Corporation Bilateral extension prosthesis and method of delivery
US6843802B1 (en) 2000-11-16 2005-01-18 Cordis Corporation Delivery apparatus for a self expanding retractable stent
US6554827B2 (en) * 2000-12-11 2003-04-29 Scimed Life Systems, Inc. Radio frequency ablation system
US20020138134A1 (en) * 2000-12-29 2002-09-26 Kim Young Kon Thermostent for biomedical use
US6955686B2 (en) * 2001-03-01 2005-10-18 Cordis Corporation Flexible stent
US6679911B2 (en) 2001-03-01 2004-01-20 Cordis Corporation Flexible stent
US6790227B2 (en) * 2001-03-01 2004-09-14 Cordis Corporation Flexible stent
AU784552B2 (en) * 2001-03-02 2006-05-04 Cardinal Health 529, Llc Flexible stent
US8457760B2 (en) 2001-04-13 2013-06-04 Greatbatch Ltd. Switched diverter circuits for minimizing heating of an implanted lead and/or providing EMI protection in a high power electromagnetic field environment
US8509913B2 (en) * 2001-04-13 2013-08-13 Greatbatch Ltd. Switched diverter circuits for minimizing heating of an implanted lead and/or providing EMI protection in a high power electromagnetic field environment
CA2482202C (en) 2001-04-13 2012-07-03 Surgi-Vision, Inc. Systems and methods for magnetic-resonance-guided interventional procedures
US20070088416A1 (en) 2001-04-13 2007-04-19 Surgi-Vision, Inc. Mri compatible medical leads
US9295828B2 (en) 2001-04-13 2016-03-29 Greatbatch Ltd. Self-resonant inductor wound portion of an implantable lead for enhanced MRI compatibility of active implantable medical devices
US8977355B2 (en) 2001-04-13 2015-03-10 Greatbatch Ltd. EMI filter employing a capacitor and an inductor tank circuit having optimum component values
US8989870B2 (en) * 2001-04-13 2015-03-24 Greatbatch Ltd. Tuned energy balanced system for minimizing heating and/or to provide EMI protection of implanted leads in a high power electromagnetic field environment
US8600519B2 (en) * 2001-04-13 2013-12-03 Greatbatch Ltd. Transient voltage/current protection system for electronic circuits associated with implanted leads
US8182527B2 (en) * 2001-05-07 2012-05-22 Cordis Corporation Heparin barrier coating for controlled drug release
US20020169480A1 (en) * 2001-05-10 2002-11-14 Qingsheng Zhu Method and device for preventing plaque formation in coronary arteries
US7493162B2 (en) * 2001-06-15 2009-02-17 Cardiac Pacemakers, Inc. Pulmonary vein stent for treating atrial fibrillation
US7252679B2 (en) 2001-09-13 2007-08-07 Cordis Corporation Stent with angulated struts
US7195640B2 (en) * 2001-09-25 2007-03-27 Cordis Corporation Coated medical devices for the treatment of vulnerable plaque
US20030065345A1 (en) * 2001-09-28 2003-04-03 Kevin Weadock Anastomosis devices and methods for treating anastomotic sites
US7108701B2 (en) * 2001-09-28 2006-09-19 Ethicon, Inc. Drug releasing anastomosis devices and methods for treating anastomotic sites
US7326237B2 (en) * 2002-01-08 2008-02-05 Cordis Corporation Supra-renal anchoring prosthesis
US20040215310A1 (en) * 2002-01-17 2004-10-28 Omar Amirana Stent and delivery method for applying RF energy to a pulmonary vein and the atrial wall around its ostium to eliminate atrial fibrillation while preventing stenosis of the pulmonary vein thereafter
US7029493B2 (en) * 2002-01-25 2006-04-18 Cordis Corporation Stent with enhanced crossability
US7236821B2 (en) * 2002-02-19 2007-06-26 Cardiac Pacemakers, Inc. Chronically-implanted device for sensing and therapy
US7422568B2 (en) * 2002-04-01 2008-09-09 The Johns Hopkins University Device, systems and methods for localized heating of a vessel and/or in combination with MR/NMR imaging of the vessel and surrounding tissue
US6939369B2 (en) * 2002-04-03 2005-09-06 Cook Incorporated Intraluminal graft assembly and vessel repair system
WO2003096918A1 (en) * 2002-05-15 2003-11-27 Kevin Marchitto Method and device for anastomoses
AU2003249665B2 (en) 2002-05-29 2008-04-03 Surgi-Vision, Inc. Magnetic resonance probes
US20080086196A1 (en) * 2002-06-05 2008-04-10 Dfine,Inc. Polymer matrix devices for treatment of vascular malformations
US6786202B2 (en) * 2002-09-24 2004-09-07 Caterpillar Inc Hydraulic pump circuit
US7569626B2 (en) 2003-06-05 2009-08-04 Dfine, Inc. Polymer composites for biomedical applications and methods of making
US20040267345A1 (en) * 2003-06-30 2004-12-30 Lorenzo Juan A. Balloon catheter with self-centering tip
US7670335B2 (en) 2003-07-21 2010-03-02 Biosense Webster, Inc. Ablation device with spiral array ultrasound transducer
US7247269B2 (en) * 2003-07-21 2007-07-24 Biosense Webster, Inc. Method for making a spiral array ultrasound transducer
US20050137626A1 (en) * 2003-12-19 2005-06-23 Pastore Joseph M. Drug delivery system and method employing external drug delivery device in conjunction with computer network
ATE507789T1 (en) * 2003-12-31 2011-05-15 Biosense Webster Inc COMPREHENSIVE ABLATION DEVICE ASSEMBLY HAVING DUAL EXPANDABLE ELEMENTS
EP1737391A2 (en) * 2004-04-13 2007-01-03 Cook Incorporated Implantable frame with variable compliance
US7567841B2 (en) * 2004-08-20 2009-07-28 Cardiac Pacemakers, Inc. Method and apparatus for delivering combined electrical and drug therapies
US7295874B2 (en) * 2005-01-06 2007-11-13 Cardiac Pacemakers, Inc. Intermittent stress augmentation pacing for cardioprotective effect
US20060276882A1 (en) * 2005-04-11 2006-12-07 Cook Incorporated Medical device including remodelable material attached to frame
US7381048B2 (en) * 2005-04-12 2008-06-03 Advanced Cardiovascular Systems, Inc. Stents with profiles for gripping a balloon catheter and molds for fabricating stents
US8728072B2 (en) 2005-05-12 2014-05-20 Aesculap Ag Electrocautery method and apparatus
US7942874B2 (en) * 2005-05-12 2011-05-17 Aragon Surgical, Inc. Apparatus for tissue cauterization
US7803156B2 (en) * 2006-03-08 2010-09-28 Aragon Surgical, Inc. Method and apparatus for surgical electrocautery
US8696662B2 (en) * 2005-05-12 2014-04-15 Aesculap Ag Electrocautery method and apparatus
US9339323B2 (en) * 2005-05-12 2016-05-17 Aesculap Ag Electrocautery method and apparatus
US20060271037A1 (en) * 2005-05-25 2006-11-30 Forcept, Inc. Assisted systems and methods for performing transvaginal hysterectomies
US20060270900A1 (en) * 2005-05-26 2006-11-30 Chin Albert K Apparatus and methods for performing ablation
US8932208B2 (en) * 2005-05-26 2015-01-13 Maquet Cardiovascular Llc Apparatus and methods for performing minimally-invasive surgical procedures
US7819868B2 (en) * 2005-06-21 2010-10-26 St. Jude Medical, Atrial Fibrilation Division, Inc. Ablation catheter with fluid distribution structures
US20070005061A1 (en) * 2005-06-30 2007-01-04 Forcept, Inc. Transvaginal uterine artery occlusion
US20070016242A1 (en) * 2005-07-14 2007-01-18 Israel Henry M Percutaneous device with multiple expandable struts
US7641651B2 (en) * 2005-07-28 2010-01-05 Aragon Surgical, Inc. Devices and methods for mobilization of the uterus
US7616990B2 (en) 2005-10-24 2009-11-10 Cardiac Pacemakers, Inc. Implantable and rechargeable neural stimulator
US7951185B1 (en) * 2006-01-06 2011-05-31 Advanced Cardiovascular Systems, Inc. Delivery of a stent at an elevated temperature
US20100191306A1 (en) * 2006-01-25 2010-07-29 Greatbatch Ltd. Transient voltage suppression circuit for an implanted rfid chip
US20070185479A1 (en) * 2006-02-06 2007-08-09 Liming Lau Methods and devices for performing ablation and assessing efficacy thereof
US20070225697A1 (en) * 2006-03-23 2007-09-27 Ketan Shroff Apparatus and methods for cardiac ablation
WO2007127362A2 (en) * 2006-04-26 2007-11-08 The Cleveland Clinic Foundation Apparatus and method for treating cardiovascular diseases
US8652201B2 (en) 2006-04-26 2014-02-18 The Cleveland Clinic Foundation Apparatus and method for treating cardiovascular diseases
US8574229B2 (en) 2006-05-02 2013-11-05 Aesculap Ag Surgical tool
US20070265613A1 (en) * 2006-05-10 2007-11-15 Edelstein Peter Seth Method and apparatus for sealing tissue
US8903505B2 (en) 2006-06-08 2014-12-02 Greatbatch Ltd. Implantable lead bandstop filter employing an inductive coil with parasitic capacitance to enhance MRI compatibility of active medical devices
US20080039879A1 (en) * 2006-08-09 2008-02-14 Chin Albert K Devices and methods for atrial appendage exclusion
US8728073B2 (en) 2006-10-10 2014-05-20 Biosense Webster, Inc. Multi-region staged inflation balloon
WO2009045265A1 (en) 2007-10-05 2009-04-09 Maquet Cardiovascular, Llc Devices and methods for minimally-invasive surgical procedures
US8870867B2 (en) * 2008-02-06 2014-10-28 Aesculap Ag Articulable electrosurgical instrument with a stabilizable articulation actuator
US20090198272A1 (en) * 2008-02-06 2009-08-06 Lawrence Kerver Method and apparatus for articulating the wrist of a laparoscopic grasping instrument
US20090209986A1 (en) * 2008-02-15 2009-08-20 Stewart Michael C Devices, Tools and Methods for Atrial Appendage Exclusion
US10080889B2 (en) 2009-03-19 2018-09-25 Greatbatch Ltd. Low inductance and low resistance hermetically sealed filtered feedthrough for an AIMD
US9108066B2 (en) 2008-03-20 2015-08-18 Greatbatch Ltd. Low impedance oxide resistant grounded capacitor for an AIMD
US8447414B2 (en) * 2008-12-17 2013-05-21 Greatbatch Ltd. Switched safety protection circuit for an AIMD system during exposure to high power electromagnetic fields
US8095224B2 (en) * 2009-03-19 2012-01-10 Greatbatch Ltd. EMI shielded conduit assembly for an active implantable medical device
EP2440131B1 (en) * 2009-06-08 2018-04-04 MRI Interventions, Inc. Mri-guided interventional systems that can track and generate dynamic visualizations of flexible intrabody devices in near real time
US8396532B2 (en) 2009-06-16 2013-03-12 MRI Interventions, Inc. MRI-guided devices and MRI-guided interventional systems that can track and generate dynamic visualizations of the devices in near real time
US8882763B2 (en) 2010-01-12 2014-11-11 Greatbatch Ltd. Patient attached bonding strap for energy dissipation from a probe or a catheter during magnetic resonance imaging
KR20120139661A (en) * 2010-02-04 2012-12-27 아에스쿨랍 아게 Laparoscopic radiofrequency surgical device
US20110208181A1 (en) * 2010-02-05 2011-08-25 Emcision Limited Methods and systems for restoring patency
US8827992B2 (en) 2010-03-26 2014-09-09 Aesculap Ag Impedance mediated control of power delivery for electrosurgery
US8419727B2 (en) * 2010-03-26 2013-04-16 Aesculap Ag Impedance mediated power delivery for electrosurgery
US9173698B2 (en) 2010-09-17 2015-11-03 Aesculap Ag Electrosurgical tissue sealing augmented with a seal-enhancing composition
US10350421B2 (en) 2013-06-30 2019-07-16 Greatbatch Ltd. Metallurgically bonded gold pocket pad for grounding an EMI filter to a hermetic terminal for an active implantable medical device
US9931514B2 (en) 2013-06-30 2018-04-03 Greatbatch Ltd. Low impedance oxide resistant grounded capacitor for an AIMD
US9427596B2 (en) 2013-01-16 2016-08-30 Greatbatch Ltd. Low impedance oxide resistant grounded capacitor for an AIMD
US10596369B2 (en) 2011-03-01 2020-03-24 Greatbatch Ltd. Low equivalent series resistance RF filter for an active implantable medical device
US11198014B2 (en) 2011-03-01 2021-12-14 Greatbatch Ltd. Hermetically sealed filtered feedthrough assembly having a capacitor with an oxide resistant electrical connection to an active implantable medical device housing
US10272252B2 (en) 2016-11-08 2019-04-30 Greatbatch Ltd. Hermetic terminal for an AIMD having a composite brazed conductive lead
US9339327B2 (en) 2011-06-28 2016-05-17 Aesculap Ag Electrosurgical tissue dissecting device
EP2811939B8 (en) 2012-02-10 2017-11-15 CVDevices, LLC Products made of biological tissues for stents and methods of manufacturing
US9883906B2 (en) 2012-04-22 2018-02-06 Newuro, B.V. Bladder tissue modification for overactive bladder disorders
US10610294B2 (en) 2012-04-22 2020-04-07 Newuro, B.V. Devices and methods for transurethral bladder partitioning
KR101415902B1 (en) 2012-05-18 2014-07-08 신경민 Catheter provided with cauterization system
BR122020022677B1 (en) 2012-09-26 2023-01-10 Aesculap Ag ELECTRO SURGICAL DEVICE FOR CUTTING AND SEALING TISSUES
USRE46699E1 (en) 2013-01-16 2018-02-06 Greatbatch Ltd. Low impedance oxide resistant grounded capacitor for an AIMD
US20140228937A1 (en) 2013-02-11 2014-08-14 Joshua Krieger Expandable Support Frame and Medical Device
WO2015200906A1 (en) * 2014-06-27 2015-12-30 Boston Scientific Scimed, Inc. Compositions, devices, kits and methods for attaching stent-containing medical devices to tissue
CN107847239B (en) 2015-06-06 2022-06-10 香港科技大学 Radio frequency electric thrombus removing device
US10053693B2 (en) * 2016-01-19 2018-08-21 Mubin I. Syed Method for controlling obesity using minimally invasive means
US10249415B2 (en) 2017-01-06 2019-04-02 Greatbatch Ltd. Process for manufacturing a leadless feedthrough for an active implantable medical device
US10905888B2 (en) 2018-03-22 2021-02-02 Greatbatch Ltd. Electrical connection for an AIMD EMI filter utilizing an anisotropic conductive layer
US10912945B2 (en) 2018-03-22 2021-02-09 Greatbatch Ltd. Hermetic terminal for an active implantable medical device having a feedthrough capacitor partially overhanging a ferrule for high effective capacitance area

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4709698A (en) * 1986-05-14 1987-12-01 Thomas J. Fogarty Heatable dilation catheter
US4795458A (en) * 1987-07-02 1989-01-03 Regan Barrie F Stent for use following balloon angioplasty
US4979518A (en) * 1986-06-13 1990-12-25 Olympus Optical Co., Ltd. Body depth heating hyperthermal apparatus

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4674481A (en) * 1983-10-31 1987-06-23 Board Of Regents, The University Of Texas System RF electromagnetic field generation apparatus for regionally-focused hyperthermia
US4799479A (en) * 1984-10-24 1989-01-24 The Beth Israel Hospital Association Method and apparatus for angioplasty
US4643186A (en) * 1985-10-30 1987-02-17 Rca Corporation Percutaneous transluminal microwave catheter angioplasty
US4733665C2 (en) * 1985-11-07 2002-01-29 Expandable Grafts Partnership Expandable intraluminal graft and method and apparatus for implanting an expandable intraluminal graft
US4790311A (en) * 1986-06-03 1988-12-13 Ruiz Oscar F Radio frequency angioplasty catheter system
US4808164A (en) * 1987-08-24 1989-02-28 Progressive Angioplasty Systems, Inc. Catheter for balloon angioplasty
US4877030A (en) * 1988-02-02 1989-10-31 Andreas Beck Device for the widening of blood vessels

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4709698A (en) * 1986-05-14 1987-12-01 Thomas J. Fogarty Heatable dilation catheter
US4979518A (en) * 1986-06-13 1990-12-25 Olympus Optical Co., Ltd. Body depth heating hyperthermal apparatus
US4795458A (en) * 1987-07-02 1989-01-03 Regan Barrie F Stent for use following balloon angioplasty

Cited By (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6071277A (en) * 1996-03-05 2000-06-06 Vnus Medical Technologies, Inc. Method and apparatus for reducing the size of a hollow anatomical structure
US6981972B1 (en) 1996-03-05 2006-01-03 Vnus Medical Technologies, Inc. Apparatus for treating venous insufficiency using directionally applied energy
US6033398A (en) * 1996-03-05 2000-03-07 Vnus Medical Technologies, Inc. Method and apparatus for treating venous insufficiency using directionally applied energy
US6033397A (en) * 1996-03-05 2000-03-07 Vnus Medical Technologies, Inc. Method and apparatus for treating esophageal varices
US6036687A (en) * 1996-03-05 2000-03-14 Vnus Medical Technologies, Inc. Method and apparatus for treating venous insufficiency
US6135997A (en) * 1996-03-05 2000-10-24 Vnus Medical Technologies, Inc. Method for treating hemorrhoids
US6139527A (en) * 1996-03-05 2000-10-31 Vnus Medical Technologies, Inc. Method and apparatus for treating hemorrhoids
US6152899A (en) * 1996-03-05 2000-11-28 Vnus Medical Technologies, Inc. Expandable catheter having improved electrode design, and method for applying energy
WO1997032532A1 (en) * 1996-03-05 1997-09-12 Vnus Medical Technologies, Inc. Vascular catheter-based system for heating tissue
US6613045B1 (en) 1996-03-05 2003-09-02 Vnus Medical Technologies, Inc. Method and apparatus for treating venous insufficiency
US5891134A (en) * 1996-09-24 1999-04-06 Goble; Colin System and method for applying thermal energy to tissue
US6231507B1 (en) 1997-06-02 2001-05-15 Vnus Medical Technologies, Inc. Pressure tourniquet with ultrasound window and method of use
US6361496B1 (en) 1997-06-02 2002-03-26 Vnus Medical Technologies, Inc. Pressure tourniquet with ultrasound window and method of use
US6165172A (en) * 1997-09-11 2000-12-26 Vnus Medical Technologies, Inc. Expandable vein ligator catheter and method of use
US6689126B1 (en) 1997-09-11 2004-02-10 Vnus Medical Technologies, Inc. Expandable vein ligator catheter and method of use
US7406970B2 (en) 1997-09-11 2008-08-05 Vnus Medical Technologies, Inc. Method of using expandable vein ligator catheter having multiple electrode leads
US6200312B1 (en) 1997-09-11 2001-03-13 Vnus Medical Technologies, Inc. Expandable vein ligator catheter having multiple electrode leads
US6398780B1 (en) 1997-09-11 2002-06-04 Vnus Medical Technologies, Inc. Expandable vein ligator catheter and method of use
US6401719B1 (en) 1997-09-11 2002-06-11 Vnus Medical Technologies, Inc. Method of ligating hollow anatomical structures
US7041098B2 (en) 1997-09-11 2006-05-09 Vnus Medical Technologies, Inc. Expandable vein ligator catheter and method of use
US6179832B1 (en) 1997-09-11 2001-01-30 Vnus Medical Technologies, Inc. Expandable catheter having two sets of electrodes
US6682526B1 (en) 1997-09-11 2004-01-27 Vnus Medical Technologies, Inc. Expandable catheter having two sets of electrodes, and method of use
US6237606B1 (en) 1997-09-11 2001-05-29 Vnus Medical Technologies, Inc. Method of applying energy to tissue with expandable ligator catheter having multiple electrode leads
US6752803B2 (en) 1997-09-11 2004-06-22 Vnus Medical Technologies, Inc. Method and apparatus for applying energy to biological tissue including the use of tumescent tissue compression
US6969388B2 (en) 1997-09-11 2005-11-29 Vnus Medical Technologies, Inc. Apparatus for applying energy to biological tissue including the use of tumescent tissue compression
US6769433B2 (en) 1997-09-11 2004-08-03 Vnus Medical Technologies, Inc. Expandable vein ligator catheter having multiple electrode leads, and method
US6014589A (en) * 1997-11-12 2000-01-11 Vnus Medical Technologies, Inc. Catheter having expandable electrodes and adjustable stent
US6263248B1 (en) 1997-11-12 2001-07-17 Vnus Medical Technologies, Inc. Catheter having expandable electrodes and adjustable stent
US7794488B2 (en) 1998-11-06 2010-09-14 Boston Scientific Scimed, Inc. Rolling membrane stent delivery system
US6942682B2 (en) 1998-11-06 2005-09-13 Boston Scientific Scimed, Inc. Rolling membrane stent delivery system
US8377109B2 (en) 1998-11-06 2013-02-19 Boston Scientific Scimed, Inc. Rolling membrane stent delivery system
US6544278B1 (en) 1998-11-06 2003-04-08 Scimed Life Systems, Inc. Rolling membrane stent delivery system
US7335229B2 (en) 2001-02-08 2008-02-26 Boston Scientific Scimed, Inc. Vascular stent with composite structure for magnetic resonance imaging capabilities
US7766958B2 (en) 2001-02-08 2010-08-03 Boston Scientific Scimed, Inc. Vascular stent with composite structure for magnetic resonance imaging capabilities
US7988719B2 (en) 2001-02-08 2011-08-02 Boston Scientific Scimed, Inc. Vascular stent with composite structure for magnetic resonance imaging capabilities
US6767360B1 (en) 2001-02-08 2004-07-27 Inflow Dynamics Inc. Vascular stent with composite structure for magnetic reasonance imaging capabilities
EP1549247A4 (en) * 2002-09-30 2007-10-31 Mediplex Corp Drug release from antithrombogenic multi-layer coated stent
EP1549247A1 (en) * 2002-09-30 2005-07-06 Mediplex Corporation Drug release from antithrombogenic multi-layer coated stent
US9547123B2 (en) 2007-04-27 2017-01-17 Covidien Lp Systems and methods for treating hollow anatomical structures
US9770297B2 (en) 2008-06-04 2017-09-26 Covidien Lp Energy devices and methods for treating hollow anatomical structures
US9931232B2 (en) 2010-10-21 2018-04-03 Boston Scientific Scimed, Inc. Stent delivery system

Also Published As

Publication number Publication date
AU1194392A (en) 1992-08-27
US5178618A (en) 1993-01-12

Similar Documents

Publication Publication Date Title
US5178618A (en) Method and device for recanalization of a body passageway
EP0994670B1 (en) Device for preventing restenosis
US6238421B1 (en) Induction heating device and method for metallic implants in living beings
US7505812B1 (en) Electrosurgical system for treating restenosis of body lumens
EP2043553B1 (en) Stent crack reduction
US6258118B1 (en) Removable support device
JP5307900B2 (en) Selective energy storage without knowledge of organizational topography
US20080033524A1 (en) Heated balloon assembly for delivery of polymeric stents
US5775338A (en) Heated perfusion balloon for reduction of restenosis
US5292321A (en) Thermal balloon angioplasty with thermoplastic stent
US5827322A (en) Shape memory locking mechanism for intravascular stents
US5976152A (en) Method and system for deploying shape memory prostheses with heated fluid
US5603731A (en) Method and apparatus for thwarting thrombosis
US6413273B1 (en) Method and system for temporarily supporting a tubular organ
US6190355B1 (en) Heated perfusion balloon for reduction of restenosis
US20010044596A1 (en) Apparatus and method for treatment of vascular restenosis by electroporation
US20080039921A1 (en) Balloon Catheter
US20080004692A1 (en) Dynamically adjustable vascular stent
US20040106952A1 (en) Treating arrhythmias by altering properties of tissue
WO1991016864A1 (en) Method and apparatus for maintaining patency in vivo
WO1993015787A1 (en) Biodegradable stent
US20030163190A1 (en) High temperature stent delivery system
KR20200002862A (en) Stenosis Treatment
Yi et al. Wireless hyperthermia stent system for restenosis treatment and testing with swine model
JP2510428B2 (en) Balloon catheter

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AU CA JP

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IT LU MC NL SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: CA